[By NBC-1TV H. J Yook]Regus (www.regus.com), the global workplace provider, has opened its 2,000th global location. The continued growth of its network illustrates the strength of global demand for more flexible and less fixed working. Mark Dixon, Group CEO and founder, Regus plc: “We continue to grow our network in response to strong customer demand, underpinned by the ongoing move to flexible working. It’s no surprise that our 2,000th location is in the US, our largest market and also the one where we continue to see huge potential.” Based on recent Regus global research, more than a third (
[By NBC-1TV H. J Yook] Neos Therapeutics, Inc. (“Neos” or “the Company”), a highly differentiated oral drug delivery company with a portfolio of proprietary technologies and a late-stage pipeline of innovative controlled release (CR) products for ADHD, announced today that it has been granted a patent covering its novel amphetamine ADHD products. Neos has developed an extended release (XR) amphetamine oral disintegrating tablet (ODT) and an extended release amphetamine liquid suspension both of which are expected to be filed for FDA approval in the next 12-15 months. “We are pleased with the g
[By NBC-1TV H. J Yool]The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ), the world's leading provider of market technology, today announced the launch of its SMARTS FX Trade Surveillance for global foreign exchange (FX) trading. The SMARTS FX Trade Surveillance module gives surveillance and compliance teams the ability to monitor trading in FX products for possible manipulation of rate fixes, insider trading/front-running, unusual pricing and other suspect behaviors. As a means to monitor and mitigate risks associated with the FX market, the new SMARTS FX offering provides a comprehensive visualization
[By NBC-1TV H. J Yook]LFB SA, through its U.S. subsidiary, announced today that the first patient has begun treatment with LR769 in a Phase 3 clinical trial of this novel recombinant form of human Factor VIIa in patients with congenital hemophilia A or B with inhibitors. This Phase 3 clinical trial is a global open-label, multicenter study designed to evaluate the efficacy, safety and pharmacokinetics of LR769 in adolescent and adult hemophilia A and B patients with inhibitors. The study will evaluate two dosing regimens for the treatment of bleeding episodes and should be completed in 2015. M
[By NBC-1TV H. J Yook]Smartmatic, the world leader in electronic voting, has unveiled its new website. Smartmatic.com (www.smartmatic.com) now features a wealth of information covering the various electoral technologies and services that have earned Smartmatic its place at the head of the automated elections industry. “Revamping our website was a crucial strategic step for us. It now has a more attractive look and feel, an intuitive navigation structure and very engaging content. Besides showcasing our experience and our prowess to electoral authorities seeking solid and proven solutions that
[By NBC-1TV H. J Yook]Oberthur Technologies, a world leader in digital security solutions for the mobility space and Telefnica Germany, one of the leading MNOs in Germany, today announced massive deliveries of OT’s MultiSIM for O2 in Germany. OT developed the MultiSIM form factor and adjusted it according to Telefnica Germany requirements. From now on, O2 customers do not need to worry anymore, as their new SIM card will fit into any mobile phone. If they want to change from one form factor to another, they do not need to ask their operator for a new SIM card, but can just deplug their MultiSI
[By NBC-1TV H. J Yook]Toshiba Corporation (http://goo.gl/p8j1Ek, TOKYO: 6502) today announced that it will demolish the No. 2 semiconductor fabrication facility (Fab 2) at Yokkaichi Operations, the company’s NAND Flash memory plant in Mie prefecture, Japan, and replace it with a new fab on the same site. Toshiba also entered into a non-binding memorandum of understanding with SanDisk Corporation (NASDAQ: SNDK) to invest jointly in the new facility. The primary purpose of the new wafer fab is to secure space for converting existing Toshiba and SanDisk 2D NAND capacity to 3D NAND beginning in 20
[By NBC-1TV H. J Yook]With an eye on showing consumers that accuracy and comfort should not have to be sacrificed for good looks, LG Electronics (LG) will introduce its first fitness wearable devices to consumers starting this month. LG Lifeband Touch and Heart Rate Earphones offer practical features and the most accurate data collection and analysis currently available, making it easier for wearers to take control of their health. Both devices can be wirelessly connected to most of today’s popular smartphones to create a full-featured wearable ecosystem. LG Lifeband Touch features a bright, f